Celularity (CELU) Gains from Investment Securities (2019 - 2025)

Celularity (CELU) has reported Gains from Investment Securities for 7 consecutive years, with -$2.0 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Gains from Investment Securities fell 27.41% year-over-year to -$2.0 million; the TTM figure through Dec 2025 stood at $3.3 million (up 933.67% YoY), while the FY2025 annual figure was $3.8 million, up 1055.78% from the prior year.
• Gains from Investment Securities eased to -$2.0 million in Q4 2025 per CELU's latest filing, from $4.3 million in the prior quarter.
• Across five years, Gains from Investment Securities topped out at $98.2 million in Q4 2023 and bottomed at -$43.2 million in Q2 2022.
• Historically, Gains from Investment Securities has averaged $4.8 million across 5 years, with a median of -$54000.0 in 2023.
• Annual changes were most pronounced in 2024 — Gains from Investment Securities slumped 5327.61% — and 2025, when it surged 697.2%.
• Celularity's Gains from Investment Securities stood at $4.4 million in 2021, then jumped by 618.13% to $31.3 million in 2022, then surged by 213.34% to $98.2 million in 2023, then slumped by 101.58% to -$1.6 million in 2024, then dropped by 27.41% to -$2.0 million in 2025.
• Business Quant data shows CELU's Gains from Investment Securities at -$2.0 million in Q4 2025, $4.3 million in Q3 2025, and $1.3 million in Q2 2025.